Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolff

Showing results (821-830 of 973) with videos related to

Pageof 98
Sort By:
The Oncologist|March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignanciesJibran Ahmed, Anne Knisely, Carlos Torrado, et al.
JAMA Oncology|April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical TrialRachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
The American Journal of Surgical Pathology|February 4, 2012
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane, Gauri R Varadhachary, John S Yordy, et al.
Cancer|October 27, 2011
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcomeDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiformeSteven De Vleeschouwer, Steffen Fieuws, Stefan Rutkowski, et al.
Plos One|August 30, 2017
Clinical utility of circulating cell-free DNA in advanced colorectal cancerAllan A Lima Pereira, Maria Pia Morelli, Michael Overman, et al.
Journal of the American College of Surgeons|May 13, 2008
Borderline resectable pancreatic cancer: the importance of this emerging stage of diseaseMatthew H G Katz, Peter W T Pisters, Douglas B Evans, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatmentN J Sanfilippo, C H Crane, J Skibber, et al.
Pageof 98

Showing results (821-830 of 973) with videos related to

Sort By:
Pageof 98
The Oncologist|March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignanciesJibran Ahmed, Anne Knisely, Carlos Torrado, et al.
JAMA Oncology|April 19, 2019
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical TrialRachna T Shroff, Milind M Javle, Lianchun Xiao, et al.
British Journal of Cancer|August 14, 2019
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinomaKrittiya Korphaisarn, Van Morris, Jenifer S Davis, et al.
The American Journal of Surgical Pathology|February 4, 2012
Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinomaDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane, Gauri R Varadhachary, John S Yordy, et al.
Cancer|October 27, 2011
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcomeDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiformeSteven De Vleeschouwer, Steffen Fieuws, Stefan Rutkowski, et al.
Plos One|August 30, 2017
Clinical utility of circulating cell-free DNA in advanced colorectal cancerAllan A Lima Pereira, Maria Pia Morelli, Michael Overman, et al.
Journal of the American College of Surgeons|May 13, 2008
Borderline resectable pancreatic cancer: the importance of this emerging stage of diseaseMatthew H G Katz, Peter W T Pisters, Douglas B Evans, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatmentN J Sanfilippo, C H Crane, J Skibber, et al.
Pageof 98